Dasatinib and Atrovent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dasatinib (dasatinib) and Atrovent (ipratropium bromide). Common drug interactions include asthenia among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Dasatinib and Atrovent. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Dasatinib?

Dasatinib has active ingredients of dasatinib. eHealthMe is studying from 9,407 Dasatinib users. Check the latest studies of Dasatinib.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

On Apr, 09, 2026

15 people who take Dasatinib and Atrovent together, and have interactions are studied.

Dasatinib and Atrovent drug interactions.

What are the common drug interactions of Dasatinib and Atrovent, by gender? *:

female:

Asthenia (weakness)
Pleural effusion (water on the lungs)
Pyrexia (fever)
Vomiting
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Multi-organ failure (multisystem organ failure)
Bacterial sepsis
Coma (state of unconsciousness lasting more than six hours)
Enterocolitis bacterial

male:

Dyspnoea (difficult or laboured respiration)
Anxiety
Malignant pleural effusion (a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue lining of lung)
Rash
Respiratory failure (inadequate gas exchange by the respiratory system)
Arthralgia (joint pain)
Depression
Pericardial effusion (fluid around the heart)
Pericarditis (inflammation of the pericardium)
Pleural effusion (water on the lungs)

What are the common drug interactions of Dasatinib and Atrovent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Dyspnoea (difficult or laboured respiration)
Anxiety
Pneumonia
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Hypoxia (low oxygen in tissues)
Pulmonary embolism (blockage of the main artery of the lung)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Neoplasm malignant (cancer tumour)
Asthenia (weakness)
Decreased appetite

60+:

Asthenia (weakness)
Pleural effusion (water on the lungs)
Escherichia infection (bacterial infection by escherichia coli)
Urinary tract infection bacterial
Colitis (inflammation of colon)
Dyspnoea (difficult or laboured respiration)
Respiratory failure (inadequate gas exchange by the respiratory system)
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Peripheral swelling

What are the existing conditions these people have? *

Nausea And Vomiting: 7 people, 46.67%
Cough: 7 people, 46.67%
High Blood Cholesterol: 7 people, 46.67%
Lung Cancer - Non-Small Cell (lung cancer): 7 people, 46.67%
Nausea (feeling of having an urge to vomit): 7 people, 46.67%
Stress And Anxiety: 5 people, 33.33%
Constipation: 5 people, 33.33%
Dyspnea (difficult or laboured breathing): 5 people, 33.33%
Pain: 5 people, 33.33%
Wax Blockage: 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dasatinib and Atrovent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously